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INTRODUCTION
Hydroxyapatite (HAp) scaffolds have become an 
alternative to autologous bone grafts in orthopedic 
surgery, because of the decreased operation time and 
complication risks at the graft donor site (e.g. crista iliaca), 
such as infection, excessive traumatization and post-
operative pain (10). Up to 39% of patients complain of 
chronic pain at the donor site, other complaints include 
nerve damage, disturbed gait, hernias and fractures. 
HAp scaffolds have an advantage over autologous grafts, 
because it is possible to fill larger scale bone defects with 
it due to the limited amounts of available autologous 
graft material (7). 
Principal features of biomaterials that could substitute 
bone grafts, including osteoconductivity, osteoinductivity and 
osteogenecity, were postulated by Marshall Urist in 1965 
on the basis of demineralized bone matrix (DBM) (10). 
Osteoconductivity describes two processes: osteoconversion 
(the ability of bone tissue to grow into the scaffold and 
replace it) and osteointegration (the ability of the scaffold 
to fixate to surrounding bone tissue) (8). HAp is a highly 
crystalline form of calcium phosphate and is similar 
to the mineralized phase of the bone. It has a porous 
structure, which defines the excellent osteoconductive 
potential of HAp (5, 12). Osteoconduction is a three-
dimensional process, which includes vascularization 
(in-growth of capillaries with perivascular tissue and 
subsequent migration of osteoprogenitor cell. There 
is evidence that, when comparing to a control group, 
where no scaffold is used, use of HAp to fill bone defects 
improves tissue organization, decreases amounts of 
fibrous scar tissue by promoting ossification, it also 
stimulates angiogenesis and allows forming blood 
vessel shunts through the defect (11). Another study 
stressed osteoconductivity of HAp in vivo in 2.5 year 
follow-up study on dogs (18). Osteoinductivity describes 
the ability of this biomaterial to stimulate bone tissue 
formation through various biochemical pathways with 
certain growth factors and cytokines (4, 7). HAp has a 
relatively high biocompatibility. In an in vivo study on 
mice inflammatory reaction (proved histologically and 
by reverse transcriptase Polymerase Chain Reaction 
(RT-PCR) using IL-1 as an inflammatory marker) to 
subcutaneous HAp implantation was significantly lower 
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than to implantation of DBM (10).  Several in vivo 
studies state the possibility to utilize HAp as carrier of 
growth factors to induce ossification, including bone 
morphogenetic protein – 2 (BMP-2) (5, 19).  BMPs 
induce bone formation and induce the undifferentiated 
mesenchymal cells to differentiate to osteogenic cells. 
Other factors that seem to promote bone formation 
are insulin-like growth factor (IGF-1), basic fibroblast 
growth factor (bFGF) and vascular endothelial growth 
factor (VEGF) (4, 12). Osteogenecity is obtained if 
biomaterial scaffold is coated or by any other means has 
access to osteogenic precursor cells, which subsequently 
differentiate and form bone tissue (7, 12).
Stems cells are undifferentiated cells that can proliferate 
and renew its population and have a potential to 
differentiate into various cell lineages (12).  Stem cells in 
regenerative medicine have been applied to such organs 
as nerves, blood vessels and heart (17).  Mesenchymal 
stem or stromal cells (MSCs) can be acquired from bone 
marrow by aspiration with a puncture needle (13, 15, 
17). MSCs account for 0.0015 % of subcellular bone 
marrow component (17), and have been successfully 
used for bone regeneration in in vivo studies on animals 
and humans (14). MSCs can differentiate into different 
types of cells, including chondrocytes, myocytes, and 
osteoblasts (15). One of the main issues with exploiting 
MSCs in regenerative medicine is the inability to 
provide these cells with adequate biochemical stimuli, 
needed to guide the differentiation of MSCs into the 
necessary lineage, and, therefore, several studies point 
out the need to add an exogenous soluble growth factor 
(12, 13). Another issue is the medium, by which MSCs 
are delivered into tissue so that these cells are sustained 
at the necessary site (12, 13). A promising method in 
bone regeneration is to load MSCs on to a HAp scaffold; 
several studies have demonstrated better results with this 
method, than when single HAp scaffold was implanted 
(13, 15, 17).  One in vivo study on dogs compared HAp 
coated with MSCs with a control group, where HAp 
was implanted into the bone defect without the coating. 
The results demonstrated better vascularization in 
regenerated tissue in the experimental group. Authors 
also pointed out that HAp in the control group was 
encapsulated by fibrotic tissue, which was not observed 
in the experimental group (17).
AIM OF THE STUDY
The aim of our study is to compare subcutaneous tissue 
reaction of experimental animals to implantation of 
HAp and HAp that is coated with BM-MSCs.\
MATERIALS AND METHODS
Implants:
HAp implants were produced in Riga Technical University 
Riga Biomaterials Innovation and Development centre. 
The wet precipitation reaction between calcium 
hydroxide and phosphoric acid was used to obtain the 
hydroxyapatite powder. The powder was formed in 
porous shape and sintered at 1150 oC for two hours. 
Experimental animals and BM-MSCs: 
The Animal Ethics Committee of Latvian Food and 
Veterinary Administration gave permission to use 
rabbits for morphofunctional study (Number 24, 
02.07.2010). In the study 4 New Zealand male rabbits 
were included. Biopsy of spongious bone tissue was 
taken from crista iliaca dextra (January 26, 2011) of 
each rabbit, subsequently this material was grinded 
and incubated with Type XI collagenase. The cells from 
this substance were than cultured in an environment 
containing Dulbecco’s Modified Eagle’s Medium 
(DMEM), fetal bovine serum 20% (FBS) and penicillin/
streptomycin. Cells went through three cell passages, 
achieving at least 70% confluence of adherent cells. 
Bone marrow mesenchymal stromal cells (BM-MSCs) 
were obtained from bone marrow of 4 rabbits. These 
cells are not proven to be MSCs yet, however they are 
not haemopoetic cells. Obtained cells were adherent 
and morphologically similar to MSCs. BM-MSCs were 
immunohistochemically evaluated in Part I of the 
experiment that is outlined in the section called Staining 
and microscopical evaluation (Table 1).
On February 9, 2011 HAp implants were coated with 
100’000 BM-MSCs. The autologous BM-MSCs coated 
HAp implants were implanted into the subcutaneous 
tissue of the first 2 rabbits on the right side of the spine – 
the experimental side. On the left side of the spine – the 
control side – single HAp implants without BM-MSCs 
coating were implanted.
On March 8, 2011 euthanasia by air embolisation was 
performed. Rabbits received general anaesthesia with 
Ketamini 15 mg/kg and Midazolami 0.5 mg/kg i/m 
and additional local anaesthesia with Sol. Lidocaini 
2% (4 mg/kg). Afterwards specimens of subcutaneus 
tissue in the region with HAp implants were obtained 
and immersed into Stefanini solution. These specimens 
were immunohistochemically evaluated in Part II of the 
experiment that is outlined in the section called Staining 
and microscopical evaluation.
Similarly, on March 8, 2011 HAp implants coated with 
100’000 BM-MSCs and uncoated HAp were implanted 
on the right and left side of the spine of the remaining 
2 rabbits. The specimens for histological analysis were 
obtained on June 13, 2011. This is outlined in Part III of 
the experiment.
Staining and microscopical evaluation:  
The experiment can be divided into 3 parts.
Part I:
Slides containing 20’000 cells were prepared using 
Lab-tek II Chamber slide.  Material was stained 
immunohistochemically with several antibodies:
Nuclear Factor – κB1 p105 (NFkB p105/ p50, 1:100 
solution, Abcam, UK)
Heat Shock Protein 70 (HSP 70, 1:100, Abcam, UK)
In order to evaluate apoptosis staining with TUNEL kit 
(Roche, Germany) was also used. 
Part II:  
Specimens were stained with haemotoxilin and eosin 
and immunohistochemically with several types of 
antibodies: NFkB p105 (NFkB p105/ p50, 1:100 
solution, Abcam, UK), TUNEL kit (Roche, Germany), 
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HSP 70 (HSP 70, 1:100, Abcam, UK) and Wnt1 (1:100 
solution, Abcam, UK).
Part III
Specimens were stained with haemotoxilin and eosin 
and immunohistochemically with several types of 
antibodies: NFkB p105 (NFkB p105/ p50, 1:100 
solution, Abcam, UK), TUNEL kit (Roche, Germany), 
HSP 70 (HSP 70, 1:100, Abcam, UK) and Wnt1 (1:100 
solution, Abcam, UK), tumor necrosis factor-α (TNF-α, 
1:100 solution, Abcam, UK), fibroblast growth factor 
receptor 1 (FGFR1, 1:100 solution, Abcam, UK), 
vascular endothelial growth factor (VEGF, 1:50 solution, 
Dako, Denmark), matrix-metalloproteinase 2 (MMP-2 , 
1:100 solution, Leica, UK).
All specimens (3 slides for the experimental side 
and 1 slide for the control side with each staining) 
were microscoped and photographed at 200x, 250x, 
400x magnification and evaluated semi-quantitively. 
Depending on the relative quantity of positively stained 
structures, specimens were rated as having a few positive 
structures (+), moderate quantity of positive structures 
(++), numerous quantity of positive structures (+++) 
and abundant amount of positive structures (++++), 
and a negative result is equal to 0. Apoptosis index was 
also calculated in specimens stained using TUNEL kit. 
RESULTS
In the Part I of the experiment all bone marrow 
mesenchymal stromal cells have been apoptotic. BM-
MSCs with ameboid structure in the specimens of the 
first rabbit demonstrated abundant (++++) expression of 
NFκB p105 - proliferation and inflammatory marker -, 
however BM-MSCs with a mesenchymal structure 
demonstrated a negative result (0) for programmed cell 
death Table 2, Figure 1. Expression of NFκB p105 was 
numerous (+++) in all BM-MSCs in specimens of the 
second rabbit. Expression of heat shock protein 70 – 
indicator of cell stress – varied in specimens of rabbit 1 
from negative (0) in cells with mesenchymal structure 
to numerous (+++) in cells with amebic structure, and 
was numerous (+++) in specimens of the second rabbit. 
In the Part II of the experiment routine staining with 
haemotoxilin and eosin demonstrated formation of 
granulation tissue with increased vascularization around 
the HAp implant, which was more distinct on the 
control side. There was also inflammatory infiltration 
on the control side, which was not observed on the 
experimental side. Apoptosis index (70-90%), NFκB 
p105 (++++), WNT1 (++++) and HSP70 (++++) positive 
structures including endothelial cells, fibroblasts, and 
leukocytes was similar on both sides.
In the Part III of the experiment, routine microscopy 
demonstrated formation of new muscle fibers, which 
was more distinguished on the experimental side, 
some muscle fibers were vacuolised, though no signs 
of inflammation have been noticed. On the control side 
rare peri-vascular inflammation can be noticed, dense 
fibrous capsule has formed around the HAp implant. 
There was an increased number of NFκB p105 positive 
cells (fibroblasts, myocytes, endotheliocytes) on the 
experimental side (+++), in comparison to the control 
side (++) (Figure 2 and 3). HSP70 and apoptosis index 
was decreased on the experimental side (++ and 60%), 
in comparison to the control side (+++ and 70%) 
(Figure 4 and 5). Number of MMP2 positive structures 
was increased on the control side in the fibrous capsule 
(++), in comparison to the experimental side, where the 
result varied (0 - +). 
DISCUSSION
All cultured bone marrow mesenchymal stromal cells 
were apoptotic. This indicates that after the BM-MSCs 
coated implants are implanted into the subcutaneous 
tissue of the rabbits, these cells will not differentiate 
further. We speculate that this might be due to the lack 
of certain cytokines and growth factors, which normally 
in vivo stimulate osteoblast precursor cells. These factors 
include bone morphogenetic protein – 2 (BMP2) (6) 
and IL-3 (1). Several studies also point out the positive 
role of fibroblast growth factor/ fibroblast growth 
factor receptor signaling system on the differentiation 
of osteoprogenitor cells (9). We speculate that these 
BM-MSCs are capable of inducing proliferation of 
subcutaneous tissue and regulating inflammatory 
reactions due to the following reasons.
BM-MSCs in this study stained positive for nuclear factor – 
kappa B p105/ p50. Several recent studies underline 
the impact of NF-kB signaling pathway on bone 
formation through both - osteoclasts and osteoblasts. 
Inactive NF-kB is located in the cells cytoplasm bound 
to the inhibitor IkB. When activated, IKK (inhibitor of 
NF- kB kinase) phosphorylates this complex and thus 
leads to the liberation and transport of NF-kB p50 to 
the nucleus, where it regulates expression of genes 
that enhance inflammatory responses and stimulate 
proliferation. Tumor necrosis factor alpha (TNF-α) is one 
of factors that could provoke the NF-kB activation (16). 
Therefore, it is possible that BM-MSCs may serve as 
inductors of inflammation and/ or proliferation after 
BM-MSCs’ coated implants are implanted into the 
subcutaneous tissue. 
The NF-kB pathway and its role in regulation of 
inflammatory response and stimulation of proliferation 
may explain the lack of distinct fibrous capsule on 
the experimental side in the III part of our study. The 
increased levels of NF-kb p105/p50, decreased apoptosis 
and tissue degradation on the experimental side may 
be also connected to the inductive stimuli of the BM-
MSCs on the HAp implants, even though these cells 
were apoptotic. This inductive function of BM-MSCs 
coated HAp implants has been described in several other 
studies (3, 17). There is evidence that BM-MSCs can 
stimulate angiogenesis by promoting VEGF expression, 
this on the other hand is beneficial for bone formation 
(17). Our experiment did not show any distinct 
difference of VEGF levels on both sides. There is also 
information that implantation of BM-MSCs has some 
immunosuppressive effects (3), this may explain the 
decreased infiltration and decreased formation of fibrous 
capsule on the experimental side. One study states that 
BM-MSCs express cytokines that inhibit apoptosis of 
surrounding cells (2).
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CONCLUSIONS
1.  Cultured BM-MSC activity is partly limited due 
to the apoptosis, which is probably induced by 
environmental factors. 
2.  BM-MSC coated HAp implant stimulates secretion 
of proliferation marker NFkBp105 in subcutaneous 
tissue, decreases cell stress, apoptosis and tissue 
degradation (decreased HSP 70, apoptotic cell count 
and MMP 2) to improve the local tissue quality and 
proving BM-MSC tissue protective effect.
Table 1. Illustrates the algorithm of manipulations 
held during the course of experiment to obtain 
specimens of subcutaneous tissue for histological 
analysis. BM-MSCs coated HAp and uncoated 
HAp were implanted on the right and left side of 
the spine in each rabbit. 
























March 8, 2011 June 13, 2011
Table 2. Semiquantitative analysis of immuno-
histochemical BM-MSCs and subcutaneus 
tissue staining.  + - a few positive structures/ 
week expression, ++ - moderate quantity of 
positive structures/ moderate expression, +++ - 
numerous quantity of positive structures/ marked 
expression, ++++ - abundant quantity of positive 



















TUNEL 100% 100% 80-90% 70-80% 60% 70%
NFκB 
p105
0/++++* +++ ++++ ++++ +++ ++










VEGF 0 - ++++ +++
MMP2 0/+ ++
* Mesenchymal cells - 0, ameboid cells - ++++ 
** Mesenchymal cells - 0, ameboid cells - +++
Fig. 1. NF-kB p105 positive bone marrow 
mesenchymal stromal cells (black arrow), rabbit 
I. Immunohistochemistry, anti- NF-kB p105, 400x. 
Fig. 2. NF-kB p105 positive endotheliocytes (pink 
arrow), myocytes (red arrow), experimental side, 
rabbit II, Immunohistochemistry, anti- NF-kB 
p105, 400x.
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Fig. 3. NF-kB p105 positive fibroblasts in the 
fibrous capsule (pink arrows), control side, rabbit 
II. Immunohistochemistry, anti- NF-kB p105, 
400x.
Fig. 4. Apoptosis of fibroblasts in the fibrous 
capsule (green arrow), control side, rabbit II, 
TUNEL, 400x. 
Fig. 5. Apoptosis of endotheliocytes, experimental 
side (green arrow), rabbit II, TUNEL, 400x
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